P1454: REAL-WORLD OUTCOMES OF BREXUCABTAGENE AUTOLEUCEL (BREXU-CEL) FOR THE TREATMENT OF RELAPSED OR REFRACTORY (R/R) MANTLE CELL LYMPHOMA (MCL) IN THE UNITED STATES (US)

• F. Locke, MD,
• Z.-H. Hu, MPH,
• J. Gerson, MD,
• M. J. Frank, PhD,
• L. E. Budde, PhD,
• M. Wang, MD,
• B. Logan, PhD,
• I. Kloos, PhD,
• R. Siddiqi, PhD,
• J. Shah, MD,
• H. Xu, PhD,
• M. Pasquini, MS

Affiliations

F. Locke, MD

1 H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL

Z.-H. Hu, MPH

2 Kite, a Gilead company, Santa Monica, CA

J. Gerson, MD

3 University of Pennsylvania, Philadelphia, PA

M. J. Frank, PhD

L. E. Budde, PhD

M. Wang, MD

6 The University of Texas MD Anderson Cancer Center, Houston, TX

B. Logan, PhD

7 Medical College of Wisconsin, Milwaukee, WI, United States of America

I. Kloos, PhD

R. Siddiqi, PhD

2 Kite, a Gilead company, Santa Monica, CA

J. Shah, MD

2 Kite, a Gilead company, Santa Monica, CA

H. Xu, PhD

M. Pasquini, MS